The document presents an overview of primary and secondary data collection methods essential for research, emphasizing the significance of accurate and valid data. It discusses the merits and demerits of both primary data—collected firsthand—and secondary data—previously accumulated by others. The importance of using high-quality data in pharmaceutical companies is highlighted, alongside recommendations for managing the disadvantages associated with secondary data.